Documentary Filmmakers Interview Prominent Attorney about the Dangers of Antidepressants

The makers of the film “Who Cares in Sweden,” interviewed Michael Baum, the senior managing partner of Baum, Hedlund, Aristei & Goldman, about the rampant use of SSRI (selective serotonin repute inhibitors) antidepressants in Sweden and the rest of the western world. The Swedish documentary shows that antidepressants are not only making people “care less,” they are exposing those who take them, to a long list of dangerous side effects.

Mr. Baum is one of several experts the filmmakers chose to provide commentary on the risks antidepressants pose, especially to women of childbearing age. As an attorney, he has spent decades working on behalf of clients who have suffered adverse reactions and serious side effects from antidepressants. He and his law firm have successfully handled thousands of wrongful death and personal injury cases stemming from major pharmaceutical antidepressant tragedies.  Michael’s penchant for biomedical research, clinical trials, and statistics has led his firm into prosecuting a vast amount of complex pharmaceutical product liability and consumer fraud cases. His work has helped uncover harmful drug industry practices, deceptive Big Pharma marketing schemes and resulted in major consumer safety advocacy work and improved drug warning labels for SSRI (selective serotonin reuptake inhibitors) antidepressants.

According to Baum, it is not widely-known in the U.S. or Sweden that these drugs are associated with serious side effects and adverse events. “More needs to be said about the negative reactions that occur,” he says in the film. “For instance, the majority of people placed on these drugs are women, and they are women of childbearing age.”

What women need to understand, says Baum, is that these drugs manipulate a molecule called a neurotransmitter, which is a signaling molecule for fetuses and embryos while they are developing. “The level of that molecule gets manipulated by the drug and can cause birth defects.”

For years, the pharmaceutical industry has downplayed the risks associated with antidepressants all while deploying countless marketing and public relations campaigns telling the world how necessary the drugs are for a wide variety of diagnoses. “Who Cares in Sweden” takes a critical look at what these drugs are doing not only to our consciousness, but to our overall health and the health of our children.